- Approval Id
- ec6a6d0cd91c74da
- Drug Name
- PAZEO OPHTHALMIC SOLUTION 0.7%
- Product Name
- PAZEO OPHTHALMIC SOLUTION 0.7%
- Approval Number
- SIN15242P
- Approval Date
- 2017-05-22
- Registrant
- NOVARTIS (SINGAPORE) PTE LTD
- Licence Holder
- NOVARTIS (SINGAPORE) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- SOLUTION, STERILE
- Dosage
- <p><strong>4.2 Posology and method of administration</strong></p>
<p>One drop in each affected eye once daily.</p>
<p><em>Pediatric Use</em><br>
The safety and effectiveness has been established in pediatric patients 2 years of age and above.</p>
<p><em>Geriatric Use</em><br>
No dosage regimen adjustment is required in patients 65 years of age or above.</p>
<p><em>Special populations</em><br>
Olopatadine Eye Drops, Solution has not been studied in patients with renal or hepatic disease. However, no dosage adjustment is expected to be necessary in hepatic or renal impairment.</p>
<p><u>Method of administration</u></p>
<ul>
<li>For topical ocular use only. Not for injection or oral use.</li>
<li>To avoid contamination, the dropper tip should not touch any surface. The dropper tip should also not come into contact with the eye as this may cause injury to the eye. When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced. This may result in a decrease in systemic side effects and an increase in local activity.</li>
<li>The bottle should be kept tightly closed when not in use.</li>
<li>If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart. Eye ointments should be administered last.</li>
<li>Patients should be advised not to wear a contact lens if their eye is red.</li>
<li>Pazeo should not be used to treat contact lens related irritation.</li>
</ul>
- Route Of Administration
- OPHTHALMIC
- Indication Info
- <p><strong>4.1 Therapeutic Indications</strong></p>
<p>PAZEO is indicated for the treatment of ocular itching associated with allergic conjunctivitis.</p>
- Contraindications
- <p><strong>4.3. Contraindications</strong><br>
Hypersensitivity to the active substance or to any of the excipients.</p>
- Atc Code
- S01GX09
- Atc Item Name
- olopatadine
- Pharma Manufacturer Name
- NOVARTIS (SINGAPORE) PTE LTD
- Company Detail Path
- /organization/novartis-singapore-pte-ltd
